Latest News
Could CBRE Group be the hidden gem you've been searching for? Our experts break down the company's strengths and weaknesses to help you decide if it's worth your investment.
Via The Motley Fool · January 2, 2026
Automotive technology company Visteon (NYSE:VC) fell short of the markets revenue expectations in Q3 CY2025, with sales falling 6.4% year on year to $917 million. The company’s full-year revenue guidance of $3.78 billion at the midpoint came in 0.8% below analysts’ estimates. Its non-GAAP profit of $2.15 per share was 1.2% above analysts’ consensus estimates.
Via StockStory · January 2, 2026
Network testing solutions company Viavi Solutions (NASDAQ:VIAV) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 25.6% year on year to $299.1 million. On top of that, next quarter’s revenue guidance ($365 million at the midpoint) was surprisingly good and 22.1% above what analysts were expecting. Its non-GAAP profit of $0.15 per share was 14.2% above analysts’ consensus estimates.
Via StockStory · January 2, 2026
Luxury cruise operator Viking (NYSE:VIK) met Wall Streets revenue expectations in Q3 CY2025, with sales up 19.1% year on year to $2 billion. Its GAAP profit of $1.15 per share was 3.7% below analysts’ consensus estimates.
Via StockStory · January 2, 2026
Rigetti Computing Stock Draws Retail Buzz After Quantum Timeline Slips And Insider Sale Surfacesrigetti-com
Via Stocktwits · January 2, 2026
Financial marketplace platform LendingTree (NASDAQ:TREE) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 18% year on year to $307.8 million. On top of that, next quarter’s revenue guidance ($285 million at the midpoint) was surprisingly good and 7.2% above what analysts were expecting. Its non-GAAP profit of $1.70 per share was 46.8% above analysts’ consensus estimates.
Via StockStory · January 2, 2026
Via MarketBeat · January 2, 2026
Food distribution company United Natural Foods (NYSE:UNFI) fell short of the markets revenue expectations in Q3 CY2025, with sales flat year on year at $7.84 billion. The company’s full-year revenue guidance of $31.8 billion at the midpoint came in 0.7% below analysts’ estimates. Its non-GAAP profit of $0.56 per share was 40.3% above analysts’ consensus estimates.
Via StockStory · January 2, 2026
Ultra low-cost airline Frontier Group Holdings (NASDAQ:ULCC) fell short of the markets revenue expectations in Q3 CY2025, with sales falling 5.2% year on year to $886 million. Its non-GAAP loss of $0.34 per share was 7.7% above analysts’ consensus estimates.
Via StockStory · January 2, 2026
The electric-car maker kicked off 2026 with a disappointing update on vehicle deliveries. But is demand about to pick back up?
Via The Motley Fool · January 2, 2026
Online gambling company Super Group (NYSE:SGHC) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 25.7% year on year to $557 million. Its GAAP profit of $0.19 per share was 27.3% above analysts’ consensus estimates.
Via StockStory · January 2, 2026
Global automotive retailer Penske Automotive Group (NYSE:PAG) met Wall Streets revenue expectations in Q3 CY2025, with sales up 1.4% year on year to $7.7 billion. Its non-GAAP profit of $3.23 per share was 5% below analysts’ consensus estimates.
Via StockStory · January 2, 2026
Homebuilding company PulteGroup (NYSE:PHM) beat Wall Street’s revenue expectations in Q3 CY2025, but sales fell by 1.6% year on year to $4.4 billion. Its non-GAAP profit of $2.96 per share was 2.5% above analysts’ consensus estimates.
Via StockStory · January 2, 2026
Animal health products manufacturer Phibro Animal Health (NASDAQ:PAHC) fell short of the markets revenue expectations in Q1 CY2026, with sales flat year on year at $347.8 million. On the other hand, the company’s outlook for the full year was close to analysts’ estimates with revenue guided to $1.46 billion at the midpoint. Its non-GAAP profit of $0.63 per share was 8.3% below analysts’ consensus estimates.
Via StockStory · January 2, 2026
An analysis and commentary on the financial markets.
Via Talk Markets · January 2, 2026
Ophthalmology biopharmaceutical company Ocular Therapeutix (NASDAQ:OCUL) reported Q3 CY2025 results topping the market’s revenue expectations, but sales fell by 5.7% year on year to $14.54 million. Its non-GAAP loss of $0.38 per share was 9.6% below analysts’ consensus estimates.
Via StockStory · January 2, 2026
Midwest regional bank Old Second Bancorp (NASDAQ:OSBC) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 34.6% year on year to $96.22 million. Its non-GAAP profit of $0.53 per share was 4.6% above analysts’ consensus estimates.
Via StockStory · January 2, 2026
Over the coming days, investors will focus on U.S. employment data and global inflation figures, as they inform central banks’ decisions.
Via Talk Markets · January 2, 2026
Today, Jan. 2, 2026, defense-driven rebranding, new funding, and fresh autonomous orders are redefining this niche wireless player.
Via The Motley Fool · January 2, 2026
Via Benzinga · January 2, 2026
On Jan. 2, 2026, industrial and cyclical names took the lead as technology stocks slipped, despite a semiconductor rally.
Via The Motley Fool · January 2, 2026
Via MarketBeat · January 2, 2026
As of January 2, 2026, BigBear.ai (NYSE: BBAI) has officially signaled the completion of a multi-year financial transformation, executing a final redemption call for its remaining convertible debt. This move effectively clears the company’s path of the high-interest obligations that have weighed on its valuation since its public
Via MarketMinute · January 2, 2026
The first trading days of 2026 have arrived with a whisper rather than a roar. As of today, January 2, 2026, the major indices are hovering near the flatline, reflecting a market caught between the momentum of a late-2025 rally and the sobering reality of a new fiscal year. This
Via MarketMinute · January 2, 2026
As the opening bell prepares to ring for the first full week of 2026, Wall Street finds itself in a state of high-octane anticipation, grappling with a paradox of prosperity. Following a two-year stretch that saw the S&P 500 (NYSE:SPY) and the Nasdaq Composite (NASDAQ:QQQ) deliver their
Via MarketMinute · January 2, 2026